← National Healthcare Properties, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | ($20.9m) |
($42.5m)
-103.83%
|
($52.8m)
-24.01%
|
($88.1m)
-66.95%
|
— | — | — | — | — | — | — | |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | — | — | ($78.8m) |
($92.9m)
-17.98%
|
($93.3m)
-0.37%
|
($86.1m)
+7.71%
|
($203.5m)
-136.36%
|
($71.1m)
+65.08%
|
— | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ($21.0m) | ($42.7m) | ($53.0m) | ($88.3m) | ($75.5m) | ($85.4m) | ($79.6m) | ($72.4m) | ($190.3m) | ($57.7m) | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | ($96k) | ($164k) | ($216k) | ($393k) | $303k | ($260k) | ($135k) | ($82k) | ($567k) | ($64k) | — | |
| Depreciation, Depletion and Amortization | $98.9m | $77.6m | $83.2m | $81.0m | $81.1m | $79.9m | $82.1m | $82.9m | $84.1m | $78.3m | $72.3m | |
| Amortization of Debt Issuance Costs | $4.5m | $6.2m | $8.6m | $9.2m | $4.1m | $4.4m | $4.9m | $6.7m | $3.4m | — | — | |
| Amortization of Debt Issuance Costs and Discounts | — | — | — | — | — | — | — | $6.8m | $3.5m | $4.8m | — | |
| Deferred Income Tax Expense (Benefit) | $327k | ($1.5m) | ($428k) | $223k | $4.6m | $0 | $0 | $0 | $0 | $0 | $1.0m | |
| Share-based Payment Arrangement, Noncash Expense | $160k | $470k | $1.2m | $1.3m | $1.3m | $1.3m | $1.2m | $919k | $613k | $3.8m | $4.4m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | — | — | — | — | $612k | — | |
| Nonoperating Income (Expense) | ($18.4m) | ($29.4m) | ($49.6m) | ($56.1m) | ($51.6m) | ($47.8m) | ($47.9m) | ($67.3m) | ($66.5m) | ($60.8m) | — | |
| Other Nonoperating Income (Expense) | — | — | — | — | — | — | — | — | — | $272k | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | $8.2m | $6.2m | $7.7m | $3.8m | $2.4m | $761k | $1.5m | $1.0m | $794k | $3.4m | ($3.7m) | |
| Net Cash Provided by (Used in) Operating Activities | $79.4m |
$64.0m
-19.45%
|
$54.2m
-15.35%
|
$47.4m
-12.46%
|
$41.8m
-11.81%
|
$38.9m
-7.00%
|
$28.3m
-27.22%
|
$21.6m
-23.58%
|
($79.8m)
-469.25%
|
$7.0m
+108.71%
|
$37.2m
+435.07%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $7.5m | $8.3m | $12.9m | $16.7m | $21.9m | $19.1m | $28.0m | $22.4m | $21.9m | $28.7m | ($28.3m) | |
| Gain (Loss) on Investments | $56k | $0 | $0 | — | — | — | $125k | $322k | — | — | ($4.5m) | |
| Gain (Loss) on Sale of Investments | $56k | $0 | $0 | $0 | — | — | $125k | $322k | — | — | — | |
| Unrealized Gain (Loss) on Investments | $6k | $0 | $0 | — | — | — | — | — | — | — | — | |
| Net Cash Provided by (Used in) Investing Activities | ($19.1m) | ($194.4m) | ($115.1m) | ($46.2m) | ($82.5m) | ($47.9m) | ($41.8m) | ($62.8m) | $64.0m | $69.8m | ($13.7m) | |
| Cash flows from financing activities: | ||||||||||||
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | — | — | $0 | $0 | $392k | $257k | — | |
| Payments for Repurchase of Common Stock | $12.2m | $33.6m | $14.2m | $21.1m | $10.5m | $0 | $0 | — | — | — | — | |
| Payments of Ordinary Dividends, Common Stock | $75.4m | $76.7m | $55.3m | $51.4m | $31.4m | $0 | $0 | $91.2m | $23.7m | $0 | ($13.3m) | |
| Proceeds from Issuance of Common Stock | $0 | $0 | $2.3b | — | — | — | — | — | — | — | — | |
| Dividends Payable | $12.9m | $11.2m | $6.6m | $6.9m | $742k | $3.4m | $3.5m | $3.5m | $3.5m | $3.3m | — | |
| Net Cash Provided by (Used in) Financing Activities | ($55.6m) |
$199.8m
+459.64%
|
$49.7m
-75.14%
|
$19.1m
-61.58%
|
$19.4m
+1.81%
|
$4.1m
-79.01%
|
$4.6m
+13.83%
|
$56.0m
+1105.49%
|
($1.3m)
-102.41%
|
($42.4m)
-3047.74%
|
($43.3m)
-2.23%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $4.1m | $69.4m | ($11.2m) | $20.2m | ($21.3m) | ($5.0m) | ($8.8m) | $14.8m | ($17.2m) | $34.4m | $106.6m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $4.1m | $102.6m | $91.4m | $111.6m | $90.3m | $85.4m | $76.5m | $91.3m | $74.1m | $108.5m | $106.6m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Payments of Financing Costs | $3.0m | $14.4m | $3.4m | $19.5m | $2.2m | $1.5m | $1.7m | $8.7m | $0 | $6.2m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $18.5m | $26.1m | $43.3m | $47.6m | $47.9m | $42.8m | $45.0m | $63.7m | $61.0m | $54.0m | — | |
| Income Taxes Paid, Net | $339k | $28k | $407k | $447k | $315k | $311k | $566k | $454k | $416k | ($10k) | — | |
| Additional Financial Items | ||||||||||||
| Gains (Losses) on Sales of Investment Real Estate | $1.3m | $438k | ($70k) | $8.8m | $5.2m | $3.6m | ($125k) | ($322k) | $9.3m | $27.8m | — | |
| General and Administrative Expense | $12.1m | $15.7m | $17.3m | $20.5m | $21.6m | $16.8m | $17.3m | $18.9m | $22.7m | $24.2m | — | |
| Income Tax Expense (Benefit) | ($2.1m) | $647k | $197k | $399k | $4.1m | $203k | $201k | $303k | $262k | $161k | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $69.4m | $61.3m | — | |
| Operating Expenses | $307.2m | $323.8m | $365.5m | $415.5m | $406.7m | $370.4m | $367.3m | $350.3m | $486.6m | $366.8m | — | |
| Operating Lease, Expense | — | — | — | $234.2m | $243.5m | $205.8m | $213.4m | $217.8m | $221.1m | $218.9m | — | |
| Proceeds from Noncontrolling Interests | $0 | $472k | $0 | $0 | — | — | — | $284k | $0 | $0 | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.